INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹97 Cr | ₹84 Cr | ₹69 Cr | ₹55 Cr | ₹43 Cr |
What is the latest Total Liabilities ratio of INDO US BIOTECH ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹97 Cr |
| Mar2024 | ₹84 Cr |
| Mar2023 | ₹69 Cr |
| Mar2022 | ₹55 Cr |
| Mar2021 | ₹43 Cr |
How is Total Liabilities of INDO US BIOTECH Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹97 Cr | 15.93 | |
| Mar2024 | ₹84 Cr | 21.65 | |
| Mar2023 | ₹69 Cr | 24.88 | |
| Mar2022 | ₹55 Cr | 27.04 | |
| Mar2021 | ₹43 Cr | - | |
Compare Total Liabilities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹202.1 Cr | -27.3% | -18.5% | -44.6% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,893.1 Cr | -6.5% | -13.4% | -5.5% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,150.9 Cr | 2.5% | -14.1% | -24.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,830.9 Cr | -2.8% | -19.4% | -19.6% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹881.6 Cr | -1.5% | -7.4% | -34.7% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹336.5 Cr | -1.3% | -15.3% | -29.7% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -27.3% |
-18.5% |
-44.6% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses